Jul. 30 at 5:39 PM
$BCTX Caveat emptor, don't buy BriaCell stock. No matter what kind of good news this company receives, the stock price ($.80 a share) barely moves - think manipulation. Also, expect a procession of offerings in the future that will futher dilute the company shares, with the shareholders taking it on the chin. Until the much anticipated FDA approvals for their clinical trials bear fruit - no telling when that will happen - you would do better buying shares in a company that is profitable.
